<i>In-Silico</i> Validation and Development of Chlorogenic Acid (CGA) Loaded Polymeric Nanoparticle for Targeting Neurodegenerative Disorders

Journals Menu

Follow SCIRP

ISSN Print: 2158-7027
ISSN Online: 2158-7043
www.scirp.org/journal/jbnb
E-mail: jbnb@scirp.org

"In-Silico Validation and Development of Chlorogenic Acid (CGA) Loaded Polymeric Nanoparticle for Targeting Neurodegenerative Disorders"
written by Vinayak Agarwal, Shriya Agarwal, Ramneek Kaur, Pranav Pancham, Harleen Kaur, Siddhi Bhardwaj, Manisha Singh,
published by Journal of Biomaterials and Nanobiotechnology, Vol.11 No.4, 2020

has been cited by the following article(s):

[1]	Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform
	Molecules, 2023

[2]	Combinatorial Assessment of Doxorubicin with Chlorogenic acid by in silico studies and development of its polymeric-nanoparticle against breast cancer
	Materials Today …, 2023

[3]	In Silico Repositioning Strategies of Theobromine and Caffeine for Psychiatric and Neurological Disorders
	Proceeding International Conference …, 2022

[4]	Dietary plant polyphenols as the potential drugs in neurodegenerative diseases: current evidence, advances, and opportunities
	… Medicine and Cellular …, 2022

[1]	Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform Molecules, 2023 DOI:10.3390/molecules28020841

[2]	Combinatorial Assessment of Doxorubicin with Chlorogenic acid by in silico studies and development of its polymeric-nanoparticle against breast cancer Materials Today: Proceedings, 2023 DOI:10.1016/j.matpr.2023.02.131

[3]	Phytopharmaceuticals and Herbal Drugs 2023 DOI:10.1016/B978-0-323-99125-4.00011-1

[4]	Phytopharmaceuticals and Herbal Drugs 2023 DOI:10.1016/B978-0-323-99125-4.00011-1

[5]	Block Co-polymeric Nanocarriers: Design, Concept, and Therapeutic Applications 2023 DOI:10.1007/978-981-99-6917-3_5

[6]	Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities Oxidative Medicine and Cellular Longevity, 2022 DOI:10.1155/2022/5288698

Follow SCIRP